News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Professor Varun Chaudhary, McMaster University, Canada

Advertisement

Articles by Professor Varun Chaudhary, McMaster University, Canada

EYLEA 8mg in focus: Key learnings from the pivotal trials

ByProfessor Varun Chaudhary, McMaster University, Canada
June 5th 2025
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Modern Retina

    1

    The gene therapy shift: A closer look at the science powering next-generation retinal treatments

    2

    How European clinicians are revolutionizing retina care

    3

    Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD

    4

    ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy

    5

    Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA

    • About
    • Advertise
    • Editorial
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us